5-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitors
-
Published:2012-05
Issue:9
Volume:22
Page:3229-3234
-
ISSN:0960-894X
-
Container-title:Bioorganic & Medicinal Chemistry Letters
-
language:en
-
Short-container-title:Bioorganic & Medicinal Chemistry Letters
Author:
Arasappan Ashok,Bennett Frank,Girijavallabhan Vinay,Huang Yuhua,Huelgas Regina,Alvarez Carmen,Chen Lei,Gavalas Stephen,Kim Seong-Heon,Kosinski Aneta,Pinto Patrick,Rizvi Razia,Rossman Randall,Shankar Bandarpalle,Tong Ling,Velazquez Francisco,Venkatraman Srikanth,Verma Vishal A.,Kozlowski Joseph,Shih Neng-Yang,Piwinski John J.,MacCoss Malcolm,Kwong Cecil D.,Clark Jeremy L.,Fowler Anita T.,Geng Feng,Kezar Hollis S.,Roychowdhury Abhijit,Reynolds Robert C.,Maddry Joseph A.,Ananthan Subramaniam,Secrist John A.,Li Cheng,Chase Robert,Curry Stephanie,Huang Hsueh-Cheng,Tong Xiao,Njoroge F. George
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference16 articles.
1. Lavanchy, D. Liver, International 2009, 29(s1), 74. 2. Mechanism of action of interferon and ribavirin in treatment of hepatitis C 3. Emerging therapies for hepatitis C virus 4. (a) Boceprevir: (i) FDA press release dated May 13, 2011, http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm255390.htm (ii) Venkatraman, S.; Bogen, S. L.; Arasappan, A.; Bennett, F.; Chen, K.; Jao, E.; Liu, Y-T.; Lovey, R.; Hendrata, S.; Huang, Y.; Pan, W.; Parekh, T.; Pinto, P.; Popov, V.; Pike, R.; Ruan, S.; Santhanam, B.; Vibulbhan, B.; Wu, W.; Yang, W.; Kong, J.; Liang, X.; Wong, J.; Liu, R.; Butkiewicz, N.; Chase, R.; Hart, A.; Agrawal, S.; Ingravallo, P.; Pichardo, J.; Kong, R.; Baroudy, B.; Malcolm, B.; Guo, Z.; Prongay, A.; Madison, V.; Broske, L.; Cui, X.; Cheng, K-C.; Hsieh, T. Y.; Brisson, J-M.; Prelusky, D.; Korfmacher, W.; White, R.; Bogdanowich-Knipp, S.; Pavlovsky, A.; Bradley, P.; Saksena, A. K.; Ganguly, A.; Piwinski, J.; Girijavallabhan, V.; Njoroge, F. G. J. Med. Chem. 2006, 49, 6074. 5. (b) (i) Telaprevir: FDA press release dated May 23, 2011, http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm256299.htm (ii) Perni, R. B.; Almquist, S. J.; Byrn, R. A.; Chandorkar, G.; Chaturvedi, P. R.; Courtney, L. F.; Decker, C. J.; Dinehart, K.; Gates, C. A.; Harbeson, S. L.; Heiser, A.; Kalkeri, G.; Kolaczkowski, E.; Lin, K.; Luong, Y.-P.; Rao, B. G.; Taylor, W. P.; Thomson, J. A.; Tung, R. D.; Wei, Y.; Kwong, A. D.; Lin, C. Antimicrob. Agents Chemother. 2006, 50, 899.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|